Pfizer (PFE)
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-11-04
$30.79+2.63%
Close 2026-11-04 · 1-day change
NYSEHealth CareDrug Manufacturers - GeneralSnapshot 2026-11-04
QuarterlyIQ Insights · PFE
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -2.9% |
| Our one-year growth estimate | diamond | -4.4% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the opposite direction.
Price observations: 365 days
Most sensitive to the US dollar.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 1.5 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 10 industry peers · Company calendar date is not available
PFE — CFO transition
Dated 2026-11-03
CFO — Cecile Guegan: The filing announces the permanent appointment of an internal employee (previously Interim CFO) to the role of Chief Financial Officer, which is a succession/promotion event rather than a departure.
Why it matters: Cecile Guegan became interim CFO on August 16 while Pfizer searches for a permanent leader. A named hire would close the open role.
Supportive ifPfizer names a permanent CFO in a press release or filing.
Worry ifPfizer reports that the CFO search remains open or extends the interim role.
Why it matters: Pfizer plans these savings from 2027 through 2029. The next reports can show whether the plan is on track.
Watch forPfizer reports progress toward the added $2.5 billion in savings and keeps the 2027–2029 timing.
Also watch forPfizer cuts the $2.5 billion savings target or pushes savings beyond 2029.
Why it matters: Pfizer raised its 2026 revenue midpoint but kept its profit range. Q3 results will test both calls.
Watch forQ3 revenue is at least $15.0 billion, and adjusted EPS is at least $0.77. Pfizer keeps its $60.5–$62.5 billion revenue and $2.80–$3.00 EPS ranges.
Also watch forQ3 revenue is below $15.0 billion or adjusted EPS is below $0.77, and Pfizer cuts either 2026 guidance range.
Why it matters: Pfizer named about 20 study starts as a 2026 goal. Meeting it would show the pipeline plan is on track.
Supportive ifPfizer reports that it expects to start about 20 pivotal studies by year-end 2026.
Worry ifPfizer reports fewer than 20 pivotal study starts in 2026, or says the goal has slipped.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$91 on $10,000 · ±0.9% | How much price usually moves either way. |
| Bad day | $222 loss on $10,000 · 2.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $1,709 loss on $10,000 · 17.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.